Max Robotics — Global Service Robot Directory + US Certification

About

Binodh DeSilva has made significant contributions to bioanalytical method development, particularly in the validation and application of ligand-binding assays (LBAs) for biotherapeutics. His key research areas include biomarker assay validation, automated bioanalytical platforms, and regulated bioanalysis of macromolecules. DeSilva’s most cited work, a 2009 paper on the “fit-for-purpose” validation of a C-terminal telopeptides of Type 1 collagen biomarker in denosumab clinical studies (33 citations), established a rigorous framework for biomarker assay qualification in drug development, directly supporting regulatory submissions. He also advanced the use of planar electrochemiluminescence platforms for macromolecule analysis (11 citations), addressing critical assay range limitations in regulated studies. Notably, DeSilva developed a generic template for automated LBAs using modular robotic scripts (2013), which streamlined discovery-stage bioanalysis by reducing manual pipetting and script-writing time. This innovation enabled high-throughput screening of biotherapeutic candidates. His work bridges the gap between assay automation and regulatory compliance, impacting both early discovery and late-stage clinical testing. DeSilva’s contributions have been instrumental in improving efficiency and reliability in bioanalytical laboratories, making him a respected figure in the field of biotherapeutic bioanalysis.